ClinicalTrials.govpublic full text
Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma
pancreatic adenocarcinoma (ductal adenocarcinoma), national multicentric phase iii superiority trial, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1033397
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.